Heart Disease Clinical Trials in Detroit

Showing 241-260 of 263 trials

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

NCT00839007

The primary objective of the study is to assess the safety and tolerability of IV administration of CD-NP and the dose relationship of CD-NP on improvement of clinical symptoms and renal function in ADHF patients.

Acute Decompensated Heart Failure

Nile Therapeutics77 participantsStarted Jun 2009

Los Angeles, California, United States • Torrance, California, United States • Jacksonville, Florida, United States +18 more locations

COMPLETEDPHASE2< 1 mile

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

NCT00455546

The study will be conducted at up to 80 centers worldwide and will be a double-blind randomized parallel group placebo controlled study among subjects with stable coronary artery disease (CAD). Subjects will be randomized to receive either placebo tablets or one of 4 orally active doses of A-002. The duration of study drug therapy will be 8 weeks.

Coronary Artery Disease (CAD)

Anthera Pharmaceuticals400 participantsStarted Apr 2007

Mobile, Alabama, United States • Scottsdale, Arizona, United States • Hot Springs, Arkansas, United States +33 more locations

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Heart Disease Trials in Other Cities

Biomarkers in Acute Heart Failure

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Fitness and Daily Function in Adults

A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators

Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Attain StarFix™ Model 4195 Left Ventricular Lead

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

The Ischemia Modified Albumin In Diagnosing Ischemic New Events

MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

Other Conditions in Detroit